- Home
- PHVS vs IMAX Comparison
PHVS vs IMAX Comparison
Compare PHVS & IMAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | PHVS | IMAX |
|---|---|---|
| Founded | 2015 | 1967 |
| Country | Switzerland | Canada |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.8B | 2.0B |
| IPO Year | 2020 | 1997 |
Fundamental Metrics
Financial Performance| Metric | PHVS | IMAX |
|---|---|---|
| Price | $26.36 | $38.31 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 10 | 9 |
| Target Price | $40.70 | ★ $44.44 |
| AVG Volume (30 Days) | 99.0K | ★ 960.6K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 31.25 |
| EPS | N/A | ★ 0.63 |
| Revenue | N/A | ★ $410,212,000.00 |
| Revenue This Year | N/A | $9.80 |
| Revenue Next Year | N/A | $7.11 |
| P/E Ratio | ★ N/A | $63.17 |
| Revenue Growth | N/A | ★ 16.47 |
| 52 Week Low | $11.51 | $20.48 |
| 52 Week High | $29.80 | $43.16 |
Technical Indicators
Market Signals| Indicator | PHVS | IMAX |
|---|---|---|
| Relative Strength Index (RSI) | 46.60 | 48.23 |
| Support Level | $24.05 | $35.94 |
| Resistance Level | $28.43 | $39.98 |
| Average True Range (ATR) | 1.16 | 1.49 |
| MACD | -0.14 | -0.20 |
| Stochastic Oscillator | 32.41 | 31.79 |
Price Performance
Historical ComparisonAbout PHVS Pharvaris N.V.
Pharvaris NV is a late-stage biopharmaceutical company which is engaged in developing novel, oral bradykinin B2 receptor antagonists to prevent and treat HAE attacks. By directly pursuing this clinically therapeutic target with novel small molecules, With positive data in both Phase 2 prophylaxis and studies in HAE, Pharvaris is developing deucrictibant. Pharvaris is currently enrolling a pivotal Phase 3 study for the treatment of HAE attacks and plans to initiate a pivotal Phase 3 study of deucrictibant for the prevention of HAE attacks.
About IMAX Imax Corporation
Imax Corp is a technology platform for entertainment and events. Through its proprietary software, auditorium architecture, patented intellectual property, and specialized equipment, IMAX offers end-to-end solution to create superior, immersive content experiences for which the IMAX brand is globally renowned. The Company has two reportable segments being Content Solutions and Technology Products and Services. The Company leverages its proprietary technology and engineering in all aspects of its business, which principally consists of the IMAX film remastering and the sale or lease of premium IMAX theater systems.